More on NRXP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NRx Pharmaceuticals (NQ:NRXP)
Delayed: 2.55 +0.06 (2.41%)
Prev. Close $2.49  
Open$2.48 
52 Wk High$ 
52 Wk Low$ 
Day High$2.59 
Day Low$2.46 
P/E N/A  
EPS$ 
Volume594,735 

Friends, Peers and Foes (?): DVLT, RDZN, MDCX, VTIX, SNYR (more...)

Oct 19, 2026 08:32 AM NRx completes manufacturing validation for preservative-free ketamine
Oct 19, 2026 08:30 AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
Oct 16, 2026 05:16 PM Form 8-K NRX Pharmaceuticals, For: Oct 16
Oct 15, 2026 08:28 AM FDA sends minor labeling comments to NRx for ketamine ANDA
Oct 15, 2026 08:27 AM NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Oct 5, 2026 05:01 PM Form 8-K NRX Pharmaceuticals, For: Sep 29
Sep 30, 2026 07:00 AM NRx Defense wins $11M DARPA contract for depression treatment trial
Sep 30, 2026 07:00 AM NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depres
Sep 16, 2026 06:02 AM Form 8-K NRX Pharmaceuticals, For: Sep 15
Sep 15, 2026 03:11 PM FDA reclassifies NRx Pharmaceuticals ketamine application amendment
View All Articles

Entities mentioned with NRXP

View All Entities